Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neurology and Therapy is Scopus-indexed (Q1, CiteScore 7.9), WoS SCIE, DOAJ. Published by Adis.
Checked against the index lists dated .
ISSN 2193-6536Verify ISSN ↗2193-8253Verify ISSN ↗
Publisher: Adis
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 60 / 403 | 85th | Q1 |
| Neurology | 32 / 201 | 84th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 7.9.
Neurology and Therapy is Q1 in Neurology (clinical) (rank 60 of 403) and Q1 in Neurology (rank 32 of 201), by CiteScore 2025.
Neurology and Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.9, which places it in quartile Q1 at the 85th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.386, quartile Q1, with an H-index of 47.
The publisher lists an article processing charge of about US$7,400 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Neurology and Therapy is published by Adis. Its print ISSN is 2193-6536 and its online ISSN is 2193-8253.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Neurology and Therapy has an h-index of 56 and a 2-year mean of 4.02 citations per paper (OpenAlex). Its Scopus CiteScore is 7.9, quartile Q1. On 2-year citations it ranks #47 of 403 Scopus journals in Neurology (clinical).
Neurology and Therapy published 180 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (25.6%), China (9.8%) and Italy (9.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.